This is the nature of the FDA pure and simple. Mild will be
This is the nature of the FDA pure and simple. Mild will be locked by Friday and severe could be stopped next week if enough value is seen that it’s seen as in humane to continue with placebo. Don’t let this press release be the reason you pay short term cap gains on all your shares before jumping back in....
From another board:
“ Refuse-to-file actions are used because FDA does not want to be locked into statutory time frames, e.g. PDUFA 6 or 10 months, until it has all the information in a form that they like. Obviously, clinical study result deficiencies would take the longest to correct. We apparently don't have that here.
Lock and unblind appears to mean that they expect to have all the data from the Phase 2 m/m trial certified and reported by the end of the week so they can unblind it and begin analysis. Obviously you can't analyze leronlimab patients vs placebo unless you know which is which (hence unblinding). They will know that at the end of the week and can start to analyze the data. Clearly they are motivated to complete the analysis as quickly as possible.
When the Phase 3 severe/critical data monitoring starts next week, if there is a tremendous difference in the death rate of the leronlimab vs placebo groups, it should be "painfully obvious". I think this is bullish because the results in the prior open label 70 eIND compassionate use patients showed dramatic evidence that leronlimab was saving lives. I am not a statistician but it seems to me that if they have 120-130 patients (I don't recall the exact number) or more, the results will be clear. Thus, I would not be surprised if the DSMC stopped the trial as soon as they looked at all the data next week so all severe/critical patients can benefit from leronlimab ASAP.
I hope this does not come to pass but I would not surprised to see hyperbolic negative and factually unbalanced or outright false posts and publications bashing leronlimab to set CYDY up for more short attacks this week before positive pivotal news with respect to the Covid trials can be announced. We have seen this movie before twice during the past two weeks. So, buckle up your safety belts for a roller coaster ride this week and next until positive news from the 2 Covid blinded trials is published.”
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A busted pipe, a fender-bender, or one bad fall can turn a promising little company into a very expensive regret. That is the plain-English value in insurance expert Michael Oehrke's overview for HelloNation: small-business insurance is not glamorous, it is not growth marketing, and it is often ignored until the owner is staring at a bill that can chew through years of...
Continue Reading
Algorithms may manufacture a flood of words, but they cannot inherit accountability. That was the sensible nerve running through Ajman Media Forum 2026, “The Signal,” inaugurated on November 19 by His Highness Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and Chairman of the Executive Council. For all the fanfare that usually surrounds artificial...
Continue Reading
Sixty-three million people carrying care responsibilities is not a side issue; it is a national load-bearing wall. The 2026 National Strategy to Support Family Caregivers arrives with that reality plainly in view, and frankly, it is overdue for the country to treat family care as core infrastructure rather than a private household problem somebody is expected to absorb...
Continue Reading
Smoke has become an expensive habit for farmers, mills, and municipalities. That is the real commercial backdrop for carbonization furnaces, not some glossy green-tech slogan. MarketsandMarkets estimates this small global equipment market at $310 million in 2026 and projects $510 million by 2031, a 10.2% compound annual growth rate. For a capital-equipment niche, that is...
Continue Reading
Medicare Advantage's audit bill just landed with a nasty thud. UnitedHealth Group shares fell more than 10% on November 18 after the Centers for Medicare & Medicaid Services proposed new anti-fraud, audit, and repayment rules for the program. For holders of NYSE:UNH, this was not some sleepy policy memo buried in a federal filing cabinet. It was a hard reminder that...
Continue Reading
A founder handing over two million of his own common shares is the sort of detail that makes investors stop stirring their coffee. Bella Rio Consulting, the company behind ROCK'N Vodka and Bella Rio Bourbon, says co-founder and Vice President Andy Roiniotis proposes to contribute 2,000,000 personally held Common shares for reclassification into Preferred Series B shares....
Continue Reading
Backup power gets interesting only after the grid has disappointed everybody. At Data Centre World Paris 2026, Ampace put its attention on that ugly, split-second handoff: utility power drops, a UPS has to catch the load immediately, and nobody operating an AI data centre gets to shrug if it does not. A Narrow Job With Brutal Consequences The company showcased its PU200...
Continue Reading
A policy switch buried in a Dutch calendar is about to rearrange millions of kitchen-table energy calculations. On 1 January 2027, the Netherlands ends net metering, or salderingsregeling, and households with solar panels will no longer offset exported power against electricity bought from the grid. That is not some abstract regulatory footnote. It changes the value of...
Continue Reading
A brain scan ordered for one reason can suddenly expose a risk nobody knew was sitting there. That is the sober promise behind MemorialCare Neuroscience Institute's rollout of Rapid Aneurysm, an artificial-intelligence tool embedded in qualifying CTA and MRA brain scans across its inpatient and outpatient network. MemorialCare says it is the first health system in Los...
Continue Reading
Millions of idle wells are sitting under America like unwanted basement clutter, and GEIOS GEOFLEX thinks some can become small, self-contained AI power plants. That is the provocative idea behind its Dark Token Factory partnership with Aiden Digital Labs: bolt an autonomous compute module onto an abandoned or non-producing oil and gas well, pull geothermal heat from...
Continue Reading
Top 5 Most Recently Viewed Articles
Canada Nickel's Significant Financing Achievement Canada Nickel Company Inc. is excited to share a major milestone in its efforts to secure financing for the Crawford Nickel Sulphide Project. The company has received a Letter of Interest (LOI) from Export Development Canada (EDC), indicating its intention to offer up to US$500 million in long-term debt financing for the...
Continue Reading
BlackRock Pursues SEC Approval for ETF Share Classes BlackRock Inc (NYSE: BLK) is making headlines as it has formally applied to the U.S. Securities and Exchange Commission (SEC) for a ruling that would allow the establishment of exchange-traded fund (ETF) share classes linked to its existing mutual funds. This significant move positions BlackRock as the largest firm...
Continue Reading
Profusa Introduces AI-Powered Insight Portal for Biomarker Monitoring Profusa, a pioneering company in digital health technology, is transforming how healthcare providers monitor patient biochemistry through an innovative AI-driven insight portal. This advanced portal will enhance continuous biomarker tracking, utilizing cutting-edge technology to provide clinical...
Continue Reading
Investigation of Pliant Therapeutics, Inc. Pliant Therapeutics, Inc. (NASDAQ: PLRX) is currently under scrutiny as investors seek clarity on potential securities law violations. This investigation presents an opportunity for shareholders who believe they have been misled regarding their investments. Shareholders are encouraged to come forward to ensure their rights are...
Continue Reading
Fish Window Cleaning Unveils New Corporate Headquarters Fish Window Cleaning Services is excited to announce the grand opening of its brand-new corporate headquarters, a facility that signifies an important milestone in its growth and operational capabilities. Located at 217 Chesterfield Towne Centre, this expansive 12,500-square-foot space is intended to serve as the...
Continue Reading